Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Adimmune Corp (4142)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
27.60 +0.30    +1.10%
01:00:00 - Closed. Currency in TWD ( Disclaimer )
  • Volume: 727,611
  • Bid/Ask: 52.50 / 52.60
  • Day's Range: 27.45 - 27.70
Type:  Equity
Market:  Taiwan
ISIN:  TW0004142005 
S/N:  4142
ADIM 27.60 +0.30 +1.10%

Adimmune Corp Company Profile

 
Get an in-depth profile of Adimmune Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

564

Equity Type

ORD

ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.

Contact Information

Address No. 3, Tanxing Road Section 1
Tanzi District Taichung, 427003
Taiwan
Phone 886 4 2538 1220
Fax 886 4 2239 5076

Top Executives

Name Age Since Title
Jung-Chin Lin 67 2019 Director
Mei-Hsing Tseng - 2017 Director
Wei-Kuang Chi - 2001 Director
Chien-Fu Chen - 2017 Director
Chung-Cheng Liu - 2012 President, GM & Director
Hsiao-Po Hsu - 2011 Independent Director
Chi-Heng Lin - 2008 Director
Chi-Hsien Chan - 2008 CEO & Chairman
Yung-Sheng Hsu - 2020 Independent Director
Mei-Hsiang He - 2017 Independent Director
Feng Xiang Yang - - Member of Supervisory Board
Ming Liang Guo - - Member of Supervisory Board
Chi-Lin Wei 75 - Member of Supervisory Board
Der-Sheng Lin - 2023 Institutional Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4142 Comments

Write your thoughts about Adimmune Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email